Keywords: japan, daiichi, sankyo, aims, sales, 960b, yen
Japan's Daiichi Sankyo aims for sales of 960B yen in 2009, by growing oversees
Article | 26 February 2007
"We are aiming at increasing sales of 785.0 billion yen ($6.44 billion) in fiscal 2006 (estimate) to 960.0 billion yen in fiscal 2009 by expanding ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
